{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:11:49Z","timestamp":1780549909900,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.semcancer.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T16:45:17Z","timestamp":1378226717000},"page":"512-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"PB","title":["A review of the current understanding and clinical utility of miRNAs in esophageal cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Naomi S.","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Samia-Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagnese","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.08.005_bib0005","series-title":"GLOBOCAN database","year":"2008"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semradonc.2006.09.003","article-title":"Epidemiology and pathogenesis of esophageal cancer","volume":"17","author":"Holmes","year":"2007","journal-title":"Semin Radiat Oncol"},{"issue":"August (16)","key":"10.1016\/j.semcancer.2013.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/jnci\/djn211","article-title":"Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age","volume":"100","author":"Brown","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"August (3)","key":"10.1016\/j.semcancer.2013.08.005_bib0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","article-title":"Demographic variations in the rising incidence of esophageal adenocarcinoma in white males","volume":"92","author":"Bollschweiler","year":"2001","journal-title":"Cancer"},{"issue":"March (11)","key":"10.1016\/j.semcancer.2013.08.005_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/gut.2007.131375","article-title":"Australian Cancer Study. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the esophagus","volume":"57","author":"Whiteman","year":"2008","journal-title":"Gut"},{"issue":"November (7)","key":"10.1016\/j.semcancer.2013.08.005_bib0035","first-page":"970","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagusesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2011","journal-title":"Gut"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0040","first-page":"70","article-title":"Esophageal cancer in Northeastern Iran: a review","volume":"10","author":"Kamangar","year":"2007","journal-title":"Arch Iran Med"},{"issue":"March (10)","key":"10.1016\/j.semcancer.2013.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3748\/wjg.v13.i10.1585","article-title":"Risk factors for Barrett's oesophagusesophagus and oesophageal adenocarcinoma: results from the FINBAR study","volume":"13","author":"Anderson","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"March (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0050","first-page":"85","article-title":"Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma","volume":"4","author":"Vaughan","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0055","unstructured":"Cancer research UK statistics [http:\/\/info.cancerresearchuk.org\/cancerstats\/]."},{"issue":"September (9)","key":"10.1016\/j.semcancer.2013.08.005_bib0060","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1245\/s10434-010-1025-0","article-title":"Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors","volume":"17","author":"Barbour","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"April (4)","key":"10.1016\/j.semcancer.2013.08.005_bib0065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.athoracsur.2008.12.060","article-title":"Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy","volume":"87","author":"Pennathur","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"November (11)","key":"10.1016\/j.semcancer.2013.08.005_bib0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gde.2005.06.012","article-title":"MicroRNAs in vertebrate development","volume":"15","author":"Harfe","year":"2005","journal-title":"Curr Opin Genet Dev"},{"issue":"February (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0085","unstructured":"miRBase [www.mirbase.org]."},{"issue":"April (4)","key":"10.1016\/j.semcancer.2013.08.005_bib0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"issue":"July (30)","key":"10.1016\/j.semcancer.2013.08.005_bib0095","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"September (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0100","first-page":"28","article-title":"Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer","volume":"3","author":"Ali","year":"2010","journal-title":"Am J Transl Res"},{"issue":"June (3)","key":"10.1016\/j.semcancer.2013.08.005_bib0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12265-010-9180-z","article-title":"Toward understanding the informatics and statistical aspects of micro-RNA profiling","volume":"3","author":"Sarver","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/0008-5472.CAN-06-4418","article-title":"Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma","volume":"68","author":"Guo","year":"2008","journal-title":"Cancer Res"},{"issue":"February (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtcvs.2007.08.055","article-title":"MicroRNA expression profiles of esophageal cancer","volume":"135","author":"Feber","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"September (18)","key":"10.1016\/j.semcancer.2013.08.005_bib0120","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1158\/1078-0432.CCR-09-0385","article-title":"MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma","volume":"15","author":"Yang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-61779-427-8_12","article-title":"MicroRNA expression analysis using the illumina microRNA-Seq platform","volume":"822","author":"Luo","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-61779-427-8_13","article-title":"Next-generation sequencing of miRNAs with Roche 454 GS-FLX technology: steps for a successful application","volume":"822","author":"Soares","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"March (12)","key":"10.1016\/j.semcancer.2013.08.005_bib0135","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/ijc.25284","article-title":"miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma","volume":"127","author":"Kano","year":"2010","journal-title":"Int J Cancer"},{"issue":"July (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.24390","article-title":"Identification of novel microRNA targets based on microRNA signatures in bladder cancer","volume":"125","author":"Ichimi","year":"2009","journal-title":"Int J Cancer"},{"issue":"June (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00795-009-0443-1","article-title":"Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR","volume":"42","author":"Ogawa","year":"2009","journal-title":"Med Mol Morphol"},{"issue":"June (7148)","key":"10.1016\/j.semcancer.2013.08.005_bib0150","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumor suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"issue":"September (15)","key":"10.1016\/j.semcancer.2013.08.005_bib0155","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.yexcr.2009.06.001","article-title":"MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer","volume":"315","author":"Lee","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2008.167817","article-title":"Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening","volume":"58","author":"Ng","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-0500-2-89","article-title":"Circulating microRNAs in breast cancer and healthy subjects","volume":"2","author":"Zhu","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.semcancer.2013.08.005_bib0170","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.bjc.6605608","article-title":"Circulating microRNAs in plasma of patients with gastric cancers","volume":"102","author":"Tsujiura","year":"2010","journal-title":"Br J Cancer"},{"issue":"August (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jso.23064","article-title":"Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma","volume":"106","author":"Kurashige","year":"2012","journal-title":"J Surg Oncol"},{"issue":"June (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/bjc.2011.198","article-title":"Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma","volume":"105","author":"Komatsu","year":"2011","journal-title":"Br J Cancer"},{"issue":"July (14)","key":"10.1016\/j.semcancer.2013.08.005_bib0185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst (Commentary)"},{"issue":"March (12)","key":"10.1016\/j.semcancer.2013.08.005_bib0190","doi-asserted-by":"crossref","first-page":"10725","DOI":"10.1074\/jbc.M110.165654","article-title":"microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"issue":"September (7)","key":"10.1016\/j.semcancer.2013.08.005_bib0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1442-2050.2011.01177.x","article-title":"Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma","volume":"24","author":"Akagi","year":"2011","journal-title":"Dis Esophagus"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/s10434-010-1213-y","article-title":"MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma","volume":"18","author":"Hummel","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"October (19)","key":"10.1016\/j.semcancer.2013.08.005_bib0205","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/1078-0432.CCR-09-1467","article-title":"MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival","volume":"15","author":"Math\u00e9","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"November (12)","key":"10.1016\/j.semcancer.2013.08.005_bib0210","first-page":"2901","article-title":"microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma","volume":"132","author":"Zhao","year":"2012","journal-title":"Int J Cancer"},{"issue":"May (9)","key":"10.1016\/j.semcancer.2013.08.005_bib0215","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1158\/1078-0432.CCR-10-2532","article-title":"Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway","volume":"17","author":"Hamano","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.semcancer.2013.08.005_bib0220","doi-asserted-by":"crossref","first-page":"e53582","DOI":"10.1371\/journal.pone.0053582","article-title":"Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ijc.25330","article-title":"Prognostic significance of differentially expressed miRNAs in esophageal cancer","volume":"128","author":"Hu","year":"2011","journal-title":"Int J Cancer"},{"issue":"December (23)","key":"10.1016\/j.semcancer.2013.08.005_bib0230","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/1078-0432.CCR-10-1110","article-title":"Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma","volume":"16","author":"Nguyen","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"December (24)","key":"10.1016\/j.semcancer.2013.08.005_bib0235","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-06-0515","article-title":"RNASEN regulates cell proliferation and affects survival in esophageal cancer patients","volume":"12","author":"Sugito","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"February (9864)","key":"10.1016\/j.semcancer.2013.08.005_bib0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"issue":"July (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2013.08.005_bib0250","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/SLA.0b013e3181dd4ea9","article-title":"The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma","volume":"251","author":"Hong","year":"2010","journal-title":"Ann Surg"},{"issue":"March (3)","key":"10.1016\/j.semcancer.2013.08.005_bib0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11605-011-1418-9","article-title":"Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells","volume":"15","author":"Hummel","year":"2011","journal-title":"J Gastrointest Surg"},{"issue":"August (3)","key":"10.1016\/j.semcancer.2013.08.005_bib0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1593\/tlo.09124","article-title":"Altered microRNA expression patterns in hepatoblastoma patients","volume":"2","author":"Magrelli","year":"2009","journal-title":"Transl Oncol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.08.005_bib0265","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.7314\/APJCP.2012.13.4.1563","article-title":"Serum miR-21 expression in human esophageal squamous cell carcinomas","volume":"13","author":"Cai","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"November (10)","key":"10.1016\/j.semcancer.2013.08.005_bib0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/CS20110207","article-title":"The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma","volume":"121","author":"Zhang","year":"2011","journal-title":"Clin Sci (Lond)"},{"issue":"August (8)","key":"10.1016\/j.semcancer.2013.08.005_bib0275","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/gut.2004.063685","article-title":"Increasing incidence of Barrett's oesophagus in the general population","volume":"54","author":"van Soest","year":"2005","journal-title":"Gut"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2013.08.005_bib0280","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/j.gastro.2009.02.002","article-title":"The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim","volume":"136","author":"Kan","year":"2009","journal-title":"Gastroenterology"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2013.08.005_bib0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/gcc.21934","article-title":"The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis","volume":"51","author":"Leidner","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"February (8)","key":"10.1016\/j.semcancer.2013.08.005_bib0290","first-page":"1036","article-title":"miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus","volume":"17","author":"Smith","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"October (7)","key":"10.1016\/j.semcancer.2013.08.005_bib0295","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.25823","article-title":"MicroRNA expression profiling in human Barrett's carcinogenesis","volume":"129","author":"Fassan","year":"2011","journal-title":"Int J Cancer"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gutjnl-2011-300178","article-title":"MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor","volume":"61","author":"Kong","year":"2012","journal-title":"Gut"},{"issue":"September (3)","key":"10.1016\/j.semcancer.2013.08.005_bib0305","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2012.1537","article-title":"Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma","volume":"41","author":"Isozaki","year":"2012","journal-title":"Int J Oncol"},{"issue":"August (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0310","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3892\/or.2012.1831","article-title":"CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma","volume":"28","author":"Suzuki","year":"2012","journal-title":"Oncol Rep"},{"issue":"May (4)","key":"10.1016\/j.semcancer.2013.08.005_bib0315","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbrc.2012.03.048","article-title":"MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma","volume":"421","author":"Xu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.semcancer.2013.08.005_bib0320","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1248\/yakushi.132.1069","article-title":"The role of microRNA-210 in esophageal squamous cell carcinoma","volume":"132","author":"Tsuchiya","year":"2012","journal-title":"Yakugaku Zasshi"},{"issue":"September (19)","key":"10.1016\/j.semcancer.2013.08.005_bib0325","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1016\/j.febslet.2012.08.007","article-title":"miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma","volume":"586","author":"Zhang","year":"2012","journal-title":"FEBS Lett"},{"issue":"November (11)","key":"10.1016\/j.semcancer.2013.08.005_bib0330","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/carcin\/bgs259","article-title":"MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis","volume":"33","author":"Wang","year":"2012","journal-title":"Carcinogenesis"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0335","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/bjc.2011.509","article-title":"Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma","volume":"106","author":"Kurashige","year":"2012","journal-title":"Br J Cancer"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0340","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cas.12030","article-title":"MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1","volume":"104","author":"Yokobori","year":"2013","journal-title":"Cancer Sci"},{"issue":"December (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0345","first-page":"197","article-title":"MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma","volume":"517","author":"Ni","year":"2012","journal-title":"Gene"},{"issue":"February (8)","key":"10.1016\/j.semcancer.2013.08.005_bib0350","first-page":"581","article-title":"MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma","volume":"52","author":"Zhang","year":"2012","journal-title":"Mol Carcinog"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2013.08.005_bib0355","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3748\/wjg.v17.i1.79","article-title":"MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145","volume":"17","author":"Wu","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"February (2)","key":"10.1016\/j.semcancer.2013.08.005_bib0360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jso.22066","article-title":"MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma","volume":"105","author":"Lin","year":"2012","journal-title":"J Surg Oncol"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T23:57:33Z","timestamp":1563839853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1044579X13000813"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.005","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the current understanding and clinical utility of miRNAs in esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}